rac-10-Methyl-14H-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one

ID: ALA4514925

PubChem CID: 140430627

Max Phase: Preclinical

Molecular Formula: C19H19N5O2

Molecular Weight: 349.39

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1CCCOc2ccccc2C(=O)Nc2cccc(n2)-c2nncn21

Standard InChI:  InChI=1S/C19H19N5O2/c1-13-6-5-11-26-16-9-3-2-7-14(16)19(25)22-17-10-4-8-15(21-17)18-23-20-12-24(13)18/h2-4,7-10,12-13H,5-6,11H2,1H3,(H,21,22,25)/t13-/m0/s1

Standard InChI Key:  LZTAURWQYWWPLU-ZDUSSCGKSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    4.2233   -5.5803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9313   -5.1730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6355   -5.5797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6355   -6.3950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9338   -6.8015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2233   -6.4003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3435   -6.8027    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0475   -6.3950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7555   -6.8027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4595   -6.3950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1676   -6.8027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9611   -6.3891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7586   -6.5581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1660   -5.8505    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6185   -5.2454    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8760   -5.5767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1679   -5.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1657   -4.3554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4573   -3.9475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7559   -4.3566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7555   -5.1720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0475   -5.5797    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3435   -5.1720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3435   -4.3567    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4638   -5.5822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1676   -7.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 12 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 22 21  1  0
 23 22  1  0
  3 23  1  0
 23 24  2  0
 21 25  1  0
 25 17  2  0
 11 26  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4514925

    ---

Associated Targets(Human)

MAP3K5 Tchem Mitogen-activated protein kinase kinase kinase 5 (1965 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 349.39Molecular Weight (Monoisotopic): 349.1539AlogP: 3.33#Rotatable Bonds:
Polar Surface Area: 81.93Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.61CX LogP: 2.66CX LogD: 2.66
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.67Np Likeness Score: -0.79

References

1. Himmelbauer MK, Xin Z, Jones JH, Enyedy I, King K, Marcotte DJ, Murugan P, Santoro JC, Hesson T, Spilker K, Johnson JL, Luzzio MJ, Gilfillan R, de Turiso FG..  (2019)  Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors.,  62  (23): [PMID:31710475] [10.1021/acs.jmedchem.9b01206]

Source